Literature DB >> 8823086

Pneumonectomy for chronic infection is a high-risk procedure.

G Massard1, A Dabbagh, J M Wihlm, R Kessler, P Barsotti, N Roeslin, G Morand.   

Abstract

BACKGROUND: The purpose of this study was to estimate operative risk, and to identify indicators of adverse prognosis, in patients undergoing pneumonectomy for chronic infection.
METHODS: Twenty-five patients aged 41 +/- 15 years underwent pneumonectomy (three completions) for chronic infection: sequelae of tuberculosis, 15; cystic bronchiectasis, 9; and radiation pneumonitis, 1. Eight patients had aspergilloma (7 after tuberculosis, 1 with radiation pneumonitis).
RESULTS: Operative mortality was 4%. Operative blood loss was estimated at 1,983 +/- 1,424 mL, ranging from 150 to 5,600 mL. A single patient required reexploration. Eight patients (32%) had empyema, and a further 3 (12%) had bronchopleural fistula; thoracoplasty was required for 10 (40%). Sequelae of tuberculosis heralded increased operative bleeding (t = 2.884; p < 0.005). Incidence of empyema or bronchopleural fistula was increased in patients with sequelae of tuberculosis (chi 2 = 3.896; p < 0.05), patients with aspergilloma (chi 2 = 4.588; p < 0.05), patients in whom the parenchymal cavities were entered (chi 2 = 11.5; p < 0.001), and those in whom blood loss was in excess of 1,000 mL (chi 2 = 4.911; p < 0.05).
CONCLUSIONS: We conclude that pneumonectomy is a high-risk procedure, especially in patients with sequelae of tuberculosis.

Entities:  

Mesh:

Year:  1996        PMID: 8823086     DOI: 10.1016/0003-4975(96)00596-6

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  9 in total

1.  Analysis of Pneumonectomy for Benign Disease: A Single Institution Retrospective Study on 59 Patients.

Authors:  Lei Yang; Chun-Liu Ding; Xiu-Jun Chang; Fu-Gen Li; Tian-Hui Zhang; Zi-Tong Wang
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-05-25       Impact factor: 1.520

2.  Outcomes after pneumonectomy for benign disease: the impact of urgent resection.

Authors:  Jacob Klapper; Sameer Hirji; Matthew G Hartwig; Thomas A D'Amico; David H Harpole; Mark W Onaitis; Mark F Berry
Journal:  J Am Coll Surg       Date:  2014-04-08       Impact factor: 6.113

3.  Surgery for patients with drug-resistant tuberculosis: report of 121 cases receiving community-based treatment in Lima, Peru.

Authors:  Jose G Somocurcio; Alfredo Sotomayor; Sonya Shin; Silvia Portilla; Maria Valcarcel; Dalia Guerra; Jennifer Furin
Journal:  Thorax       Date:  2006-08-23       Impact factor: 9.139

4.  Completion pneumonectomy after fenestration for empyema due to nontuberculous mycobacteriosis associated with destroyed lung as a result of cancer surgery.

Authors:  Ryo Takahashi; Taiki Fujiwara; Hisami Yamakawa
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

5.  Early and Long-term Outcomes of Pneumonectomy for Treating Sequelae of Pulmonary Tuberculosis.

Authors:  Chun Sung Byun; Kyung Young Chung; Kyoung Sik Narm; Jin Gu Lee; Daejin Hong; Chang Young Lee
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2012-04-03

6.  Surgical treatment for pulmonary aspergilloma - early and long-term results.

Authors:  Mariusz Kasprzyk; Kornel Pieczyński; Krystian Mania; Piotr Gabryel; Cezary Piwkowski; Wojciech Dyszkiewicz
Journal:  Kardiochir Torakochirurgia Pol       Date:  2017-06-30

7.  Factors affecting complication rates of pneumonectomy in destroyed lung.

Authors:  Aysun Kosif Mısırlıoğlu; Serkan Bayram; Hakan Kıral; Meltem Çoban Ağca; Fatma Tokgöz Akyıl; Levent Alpay; Volkan Baysungur; İrfan Yalçınkaya
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2018-04-30       Impact factor: 0.332

8.  Cavernostomy for Pulmonary Aspergillosis Associated with Destroyed Lung after Surgery for Lung Cancer: Report of 3 Cases.

Authors:  Ryo Takahashi; Taiki Fujiwara; Hisami Yamakawa
Journal:  Case Rep Surg       Date:  2015-10-20

9.  Association of positive fluid balance and cardiovascular complications after thoracotomy for noncancer lesions.

Authors:  Tanyong Pipanmekaporn; Yodying Punjasawadwong; Somrat Charuluxananan; Worawut Lapisatepun; Pavena Bunburaphong; Somchareon Saeteng
Journal:  Risk Manag Healthc Policy       Date:  2014-07-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.